Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases.
Gecilmara Cristina Salviato PileggiLicia Maria Henrique Da MotaAdriana Maria KakehasiAlexandre Wagner De SouzaAline RochaAna Karla Guedes de MeloCaroline Araujo M da FonteCecilia BortolettoClaiton Viegas BrenolClaudia Diniz Lopes MarquesCyrla ZaltmanEduardo Ferreira BorbaEnio Ribeiro ReisEutilia Andrade Medeiros FreireEvandro Mendes KlumbGeorges Basile ChristopoulosIeda Maria M LaurindoIsabella BallalaiIzaias Pereira Da CostaLessandra MichelinLilian David de Azevêdo ValadaresLiliana Andrade ChebliMarcus LacerdaMaria Amazile Ferreira ToscanoMichel Alexandre YazbekRejane Maria R De Abreu VieiraRenata MagalhãesRenato KfouriRosana RichtmannSelma Da Costa Silva MerenlenderValeria ValimMarcos Renato De AssisSergio Candido KowalskiVirginia Fernandes Moça TrevisaniPublished in: Advances in rheumatology (London, England) (2019)
This paper approaches a real need, assessed by clinicians and patient care groups, to address specific questions on the management of YFV in patients with CIMID living or traveling to YF endemic areas, involving specialists from many areas together with patients, and might have global applicability, contributing to and supporting vaccination practices. We recommended a shared decision-making approach on taking or not the YFV.